Showing posts with label Cymbalta. Show all posts
Showing posts with label Cymbalta. Show all posts
Friday, October 01, 2010

Cymbalta and Effexor: Hype Over Science

›
Remember the hype around the serotonin-norepinephrine reuptake inhibitors (SNRIs)? Effexor and Cymbalta impact both serotonin and norepine...
5 comments:
Thursday, September 25, 2008

The Cymbalta Schatz-Storm: Duplicate Publication and Lying by Omission

›
This post details the duplicate publication of data on the antidepressant duloxetine (Cymbalta). Marketing and "science" collide ...
15 comments:
Friday, July 25, 2008

Cymbalta Smacked Via Excellent Letter to Editor

›
Eli Lilly/Boehringer Ingelheim published a study claiming that duloxetine (Cymbalta) was an effective treatment for pain in depressed patie...
3 comments:
Monday, June 30, 2008

Cymbalta: Good For Whatever Ails You

›
I don't have time to write much on the topic, suffice to say that John Russell of the Indianapolis Star raises some good questions abou...
Monday, May 05, 2008

In the Name of Science and Charity

›
Philip Dawdy at Furious Seasons has noted that Eli Lilly released a short report in which they describe the funding they provided to a var...
Monday, January 07, 2008

Inaccurate Advertising Hurts

›
I'm late to the game on this post, and this material has been covered well on other sites. In case you've missed it, a recent meta-...
1 comment:
Friday, June 08, 2007

Astroturf: Welcome to the Machine

›
I welcomed y’all to the PR Machine yesterday, where I discussed the Drug Wonks blog and the general topic of how pro-industry speech is mag...
3 comments:
Monday, April 16, 2007

Lilly Posts 1Q Earnings

›
And they're pretty good. Of psych note, Zyprexa sales were up 10% compared to the 1st quarter of '06; Cymbalta sales up 89% from 1Q...
2 comments:
Thursday, March 01, 2007

Cymbalta for GAD: Pimp That Thang

›
John Mack at the Pharma Marketing Blog has laid down the smack on Cymbalta. First, he points out that the Depression Hurts campaign sure l...
2 comments:
Monday, February 26, 2007

Cymbalta for GAD: Repeating the Pattern

›
Lilly's drug Cymbalta (duloxetine, aka Yentreve) was approved by the FDA as a treatment for generalized anxiety disorder today. Is ...